[{"Assets_0_Q3_USD":1881070000.0,"CommonStockSharesOutstanding_0_Q3_shares":78440698.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-483088000.0,"NetIncomeLoss_1_Q3_USD":-307357000.0,"NetIncomeLoss_3_Q3_USD":-560567000.0,"StockholdersEquity_0_Q3_USD":1278478000.0,"Ticker":"BGNE","CIK":"1651308","name":"BEIGENE, LTD.","OfficialName":"BeiGene Ltd. American Depositary Shares","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"18163188203.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191112"}]